SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-409121
Filing Date
2015-12-21
Accepted
2015-12-21 16:14:05
Documents
5
Period of Report
2015-12-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d12870d8k.htm 8-K 17161
2 EX-5.1 d12870dex51.htm EX-5.1 8753
3 EX-99.1 d12870dex991.htm EX-99.1 8167
4 GRAPHIC g12870coo.jpg GRAPHIC 7434
5 GRAPHIC g12870sunesis.jpg GRAPHIC 3640
  Complete submission text file 0001193125-15-409121.txt   50866
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 151299602
SIC: 2834 Pharmaceutical Preparations